Biotech has really started moving again. That’s great to see. There is one huge risk here. Individual biotech can be VERY dangerous. Huge gap downs.
How do we address this risk? We buy a biotech ETF. In our case, we bought XBI.
Biotech has really started moving again. That’s great to see. There is one huge risk here. Individual biotech can be VERY dangerous. Huge gap downs.
How do we address this risk? We buy a biotech ETF. In our case, we bought XBI.